# Lidocaine Affects Collagen Breakdown Without Compromising Cell Viability in Cultured Human Tenocytes: An In Vitro Study

**Authors:** Filippo Randelli, Manuel G. Mazzoleni, Alessandra Menon, Alberto Fioruzzi, Dolaji Henin, Michele Sommariva, Nicoletta Gagliano

PMC · DOI: 10.3390/cells14130988 · Cells · 2025-06-27

## TL;DR

Lidocaine does not harm tendon cells but may increase collagen breakdown, with no protection from ascorbic acid.

## Contribution

The study clarifies lidocaine's safety on tenocyte viability and reveals its effect on collagen degradation.

## Key findings

- Lidocaine at 0.2 and 1 mg/mL did not induce apoptosis in tenocytes.
- Lidocaine increased collagen degradation without affecting collagen synthesis.
- Ascorbic acid did not protect against lidocaine-induced oxidative stress.

## Abstract

Local anesthetics (LAs) are frequently administered via peritendinous ultrasound-guided injections for diagnostic and therapeutic purposes. Since in vitro studies have demonstrated LAs’ tenotoxic effects, raising concerns about their safety in infiltrative treatments, and since lidocaine (LD) emerged as one of the most cytotoxic LAs, we analyzed apoptosis, oxidative stress, and collagen turnover pathways in human tenocytes treated with LD, as well as the possible protection from LD-induced injury elicited by antioxidant ascorbic acid (AA). Tenocytes from gluteal tendons were treated with 0.2 and 1 mg/mL LD, or left untreated (CT), and treated with 50 μg/mL or 250 μg/mL AA. Nuclear morphology, cytochrome c expression, and caspase 3 activation were analyzed to study the effect of LD on apoptosis. Heme Oxygenase 1 (HO-1) mRNA and genes and proteins involved in collagen turnover were investigated using molecular approaches. Our results show that 0.2 and 1 mg/mL LD did not induce apoptosis and did not modify collagen synthesis and maturation. Conversely, increased collagen degradation was observed, and AA was not protective against oxidative stress induction in the presence of LD. Our findings suggest that LD does not affect the cell viability of tenocytes and that peritendinous LD injections are safe in this regard. LD-associated collagen degradation and the AA buffer effect are still debatable. Overall, our study contributes to clarifying the effect of LD on tenocytes’ viability and ECM homeostasis and provides new additional information useful for the safe clinical application of this drug and for further analysis.

## Linked entities

- **Genes:** TED4 (Plant heme oxygenase (decyclizing) family protein) [NCBI Gene 817208], Casp3 (caspase 3) [NCBI Gene 12367], Cyt-c-d (Cytochrome c distal) [NCBI Gene 34995]
- **Chemicals:** lidocaine (PubChem CID 3676), ascorbic acid (PubChem CID 9888239)
- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** CASP3 (caspase 3) [NCBI Gene 836] {aka CPP32, CPP32B, SCA-1}, HMOX1 (heme oxygenase 1) [NCBI Gene 3162] {aka HMOX1D, HO-1, HSP32, bK286B10}, CYCS (cytochrome c, somatic) [NCBI Gene 54205] {aka CYC, HCS, THC4}
- **Diseases:** cytotoxic (MESH:D064420)
- **Chemicals:** AA (MESH:D001205), LD (MESH:D008012)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12248775/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12248775/full.md

## References

68 references — full list in the complete paper: https://tomesphere.com/paper/PMC12248775/full.md

---
Source: https://tomesphere.com/paper/PMC12248775